* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 57
cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 80 cents per
share.
* Revenue rose 17.6% to $1.18 million from a year ago;
analysts
expected $1.40 million.
* InspireMD Inc's reported EPS for the quarter was a loss
of 57
cents.
* The mean earnings estimate of analysts had fallen by
about 5.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* InspireMD Inc shares had fallen by 35.6% this quarter and
lost 31.8% so far this year.
* The company reported a quarterly loss of $4.48 million.
* Wall Street's median 12-month price target for InspireMD
Inc is
$9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 10 at 01:32 p.m. All
figures in US dollars unless otherwise stated